Travere Therapeutics' future revenue performance is expected...

Travere Therapeutics' future revenue performance is expected to decline, contributing to its low P/S. Shareholders accept this as they anticipate no pleasant surprises in future revenue. A strong share price rise seems unlikely under these circumstances.